- Nachrichtendetail
-
05.06.2024 15:02:17 - dpa-AFX: *ABBVIE SAYS FIRST PATIENT TREATED WITH INVESTIGATIONAL ABBV-383 IN CERVINO PHASE 3 STUDY
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Xetra | 160,220 | 26.06.24 17:35:41 | +0,260 | +0,16% | 160,080 | 160,500 | 160,240 | 160,220 |
